Long-term outcome of intralesional injection of triamcinolone acetonide for the treatment of keloid scars in Asian patients
Long-term outcome of intralesional injection of triamcinolone acetonide for the treatment of keloid scars in Asian patients
复制标题
DOI：
10.1080/02844310500430003
复制
发表时间：
2006-04-01
影响因子：
--
通讯作者：
Igawa, HH
中科院分区：
文献类型：
--
作者：
Muneuchi, G;Suzuki, S;Igawa, HH
我们研究了亚洲患者瘢痕疙瘩注射曲安奈德的长期疗效。在1985年至2003年期间，我们治疗了94名患者的109个瘢痕疙瘩疤痕，根据病变的大小，每隔四周注射1至10 mg曲安奈德。几乎没有发病率。31名患者在10次注射内因疼痛和缺乏立即改善而放弃治疗。其余63例患者中有52例（82%）主观症状改善。在客观症状方面，63例患者中有40例（63%）的结果为一般或更好，63例患者中有25例（39%）的结果为良好或更好。治疗方法需要在三到五年内注射20-30次。虽然我们没有达到像其他作者一样好的结果，但我们认为它更安全，因为我们使用了更小剂量的类固醇。
We studied the long-term outcome of injection of triamcinolone acetonide into keloid scars in Asian patients. Between 1985 and 2003, we treated 109 keloid scars in 94 patients by injecting 1 to 10 mg of triamcinolone acetonide depending on the size of the lesion at four week intervals. There was little morbidity. Thirty-one patients gave up treatment within 10 injections because of pain and lack of immediate improvement. Improvement in subjective symptoms was seen in 52 of the remaining 63 patients (82%). In objective symptoms, fair or better results were seen in 40 of 63 (63%), and good or better results in 25 of 63 (39%). The treatment method required 20-30 injections over three to five years. Although we did not achieve as good results as other authors, we think it was safer because we used a smaller dose of a steroid.